Latest Search
Quote
| Back Zoom + Zoom - | |
|
<Results> Bio-Thera Solutions (02315.HK) Swings to RMB104 million Net Profit in 1Q26
Recommend 2 Positive 0 Negative 0 |
|
|
|
|
Bio-Thera Solutions (02315.HK) announced that for 1Q26, revenue prepared under the China Accounting Standards amounted to approximately RMB433 million, representing a YoY increase of 73.68%. Net profit attributable to shareholders of the listed company was approximately RMB104 million, compared with a loss of RMB13.2458 million in the same period last year. Basic EPS was RMB0.23. During the period, research and development investment amounted to approximately RMB118 million, up 20.17% YoY. R&D investment accounted for 27.18% of revenue, representing a YoY decrease of 12.1 ppts. (ss/j) This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
|
